AUROPHARMA - Aurobindo Pharma

Aurobindo Pharma

AUROPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: K Ragunathan · MD: N Govindarajan · Listing date: June 14, 1995 · Employees: 19364 · Hyderabad · http://www.aurobindo.com

Stock Price vs Company Growth

2.5%

4.1%

5.7%

1.5%

32.9%

84.0%

7.1%

10y

15.3%

all

18.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,131 2.5%

958

1,175

Company Overview

Sales

27,895 Cr

Growth: 12.4%

Profit after Tax

2,770 Cr

Growth: 19.1%

Large Cap

66,278 Cr

P/E: 23.9x

Industry P/E: 35.5x

Fundamentals

Sales (Cr)	₹ 27,895
Growth	12.4%
EBITDA	18.4%
P/S	2.4x
Dividend	0.4%
P/E	23.9x
Book Value	₹ 497
PEG Ratio	1.9x
ROE	9.9%
P/B	2.3x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

3.46 %

Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund

3.4 %

Qualified Institutional Buyer

1.95 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund

1.32 %

Bnp Paribas Arbitrage

1.22 %

Promoters

Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)

33.51 %

K Nityananda Reddy

4.33 %

Kirthi Reddy Kambam

3.49 %

Venkata Ramprasad Reddy Penaka

3.07 %

Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)

2.85 %

Others

Increase Decrease No change

Company Profile Detailed

Aurobindo Pharma continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration.

Belongs to (33 Indices) view more

Investors (196)

aditya.b...

jhunjhun...

hdfc.tru...

Followers (73)

nitin2

keerthi

deepak